Dashboard
Manage Tickers

PACB


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

morgan-stanley-maintains-equal-weight-on-pacific-biosciences-lowers-price-target-to-4
Morgan Stanley Maintains Equal-Weight on P...
05/15/2024 14:28:07

Morgan Stanley analyst Tejas Savant maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price tar...

ambry-genetics-and-pacbio-selected-by-uci-and-gregor-consortium-to-support-pediatric-mendelian-genomics-research-center-program-to-study-rare-diseases
Ambry Genetics And PacBio Selected By UCI ...
05/15/2024 13:49:08

Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:P...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 16:31:13

sony-group-posts-upbeat-earnings-joins-gamestop-paysafe-and-other-big-stocks-moving-higher-on-tuesday
Sony Group Posts Upbeat Earnings, Joins Ga...
05/14/2024 15:01:34

expert-outlook-pacific-biosciences-through-the-eyes-of-10-analysts
Expert Outlook: Pacific Biosciences Throug...
05/13/2024 18:00:48

piper-sandler-maintains-neutral-on-pacific-biosciences-lowers-price-target-to-2
Piper Sandler Maintains Neutral on Pacific...
05/13/2024 12:57:50

Piper Sandler analyst David Westenberg maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral and lowers the price targe...

barclays-maintains-equal-weight-on-pacific-biosciences-lowers-price-target-to-2
Barclays Maintains Equal-Weight on Pacific...
05/10/2024 19:13:36

Barclays analyst Luke Sergott maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price target fr...

pacbio-expects-to-reduce-non-gaap-annualized-expense-run-rate-by-more-than-75m-by-end-of-2024-vs-initial-guidance-of-5-growth-in-2024-operating-expenses
PacBio Expects To Reduce Non-GAAP Annualiz...
05/09/2024 20:26:11

Initiated activities to reduce annualized run-rate operating expenses and the Company expects to achieve above the high end of ...

pacific-biosciences-q1-2024-adj-eps-026-beats-028-estimate-sales-38810m-miss-42962m-estimate
Pacific Biosciences Q1 2024 Adj EPS $(0.26...
05/09/2024 20:08:44

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $...

why-perficient-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-in-mondays-mid-day-session
Why Perficient Shares Are Trading Higher B...
05/06/2024 16:32:34

tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday
Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

skechers-reports-upbeat-earnings-joins-tutor-perini-appfolio-newell-brands-and-other-big-stocks-moving-higher-on-friday
Skechers Reports Upbeat Earnings, Joins Tu...
04/26/2024 14:45:17

jp-morgan-downgrades-pacific-biosciences-to-neutral
JP Morgan Downgrades Pacific Biosciences t...
04/22/2024 12:20:48

JP Morgan analyst Rachel Vatnsdal downgrades Pacific Biosciences (NASDAQ:PACB) from Overweight to Neutral.

goldman-sachs-maintains-neutral-on-pacific-biosciences-lowers-price-target-to-25
Goldman Sachs Maintains Neutral on Pacific...
04/19/2024 14:38:36

Goldman Sachs analyst Matthew Sykes maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral and lowers the price target f...

bernstein-maintains-outperform-on-pacific-biosciences-lowers-price-target-to-25
Bernstein Maintains Outperform on Pacific ...
04/18/2024 16:56:16

Bernstein analyst Eve Burstein maintains Pacific Biosciences (NASDAQ:PACB) with a Outperform and lowers the price target fro...

goldman-sachs-downgrades-pacific-biosciences-to-neutral-lowers-price-target-to-25
Goldman Sachs Downgrades Pacific Bioscienc...
04/18/2024 14:32:28

Goldman Sachs analyst Matthew Sykes downgrades Pacific Biosciences (NASDAQ:PACB) from Buy to Neutral and lowers the price ta...

scotiabank-maintains-sector-outperform-on-pacific-biosciences-lowers-price-target-to-8
Scotiabank Maintains Sector Outperform on ...
04/18/2024 11:22:12

Scotiabank analyst Sung Ji Nam maintains Pacific Biosciences (NASDAQ:PACB) with a Sector Outperform and lowers the price tar...

a-glimpse-into-the-expert-outlook-on-pacific-biosciences-through-4-analysts
A Glimpse Into The Expert Outlook On Pacif...
04/17/2024 20:00:50

td-cowen-maintains-buy-on-pacific-biosciences-lowers-price-target-to-25
TD Cowen Maintains Buy on Pacific Bioscien...
04/17/2024 15:09:17

TD Cowen analyst Daniel Brennan maintains Pacific Biosciences (NASDAQ:PACB) with a Buy and lowers the price target from $12 ...

why-invo-bioscience-shares-are-trading-higher-by-around-73-here-are-20-stocks-moving-premarket
Why INVO Bioscience Shares Are Trading Hig...
04/17/2024 10:13:57

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION